Stonepine Capital Management, LLC Quant / Systematic

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 14, 2018

Total Value: $187M (100.0% shares, 0.0% debt)

Holdings (30)

— BIOSPECIFICS TECHNOLOGIES 14.0%
Value $26.16M Shares 590,025 Share Price $44.34 Est. Cost/Share $45.13 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 10.7%
Value $20.05M Shares 5,141,746 Share Price $3.90 Est. Cost/Share $3.59 Unrealized @ Report Date —
— AMARIN CORP PLC -ADR 9.3%
Value $17.34M Shares 5,761,581 Share Price $3.01 Est. Cost/Share $3.01 Unrealized @ Report Date —
VNDA VANDA PHARMACEUTICALS INC 8.9%
Value $16.59M Shares 984,584 Share Price $16.85 Est. Cost/Share $14.90 Unrealized @ Report Date +12.3%
— APOLLO ENDOSURGERY INC 8.7%
Value $16.15M Shares 2,577,996 Share Price $6.26 Est. Cost/Share $4.75 Unrealized @ Report Date —
— VIVEVE MEDICAL INC 7.5%
Value $14.09M Shares 3,849,711 Share Price $3.66 Est. Cost/Share $6.92 Unrealized @ Report Date —
CPIX CUMBERLAND PHARMACEUTICALS 4.7%
Value $8.838M Shares 1,323,041 Share Price $6.68 * Est. Cost/Share $5.83 Unrealized @ Report Date +18.2%
— BIODELIVERY SCIENCES INTL 4.5%
Value $8.339M Shares 3,706,084 Share Price $2.25 Est. Cost/Share $2.06 Unrealized @ Report Date —
— CARDIOME PHARMA CORP 4.0%
Value $7.52M Shares 3,241,550 Share Price $2.32 Est. Cost/Share $2.49 Unrealized @ Report Date —
— NOVELION THERAPEUTICS INC 3.5%
Value $6.51M Shares 1,860,000 Share Price $3.50 Est. Cost/Share $8.14 Unrealized @ Report Date —
— ALIMERA SCIENCES INC 3.4%
Value $6.365M Shares 6,180,033 Share Price $1.03 Est. Cost/Share $1.20 Unrealized @ Report Date —
— DOVA PHARMACEUTICALS INC 2.7%
Value $4.99M Shares 184,000 Share Price $27.12 Est. Cost/Share $27.12 Unrealized @ Report Date —
— OPHTHOTECH CORP 2.3%
Value $4.365M Shares 1,593,119 Share Price $2.74 Est. Cost/Share $4.39 Unrealized @ Report Date —
VCYT VERACYTE INC 2.3%
Value $4.303M Shares 773,889 Share Price $5.56 * Est. Cost/Share $7.51 Unrealized @ Report Date -17.6%
— CONFORMIS INC 2.2%
Value $4.028M Shares 2,777,711 Share Price $1.45 Est. Cost/Share $1.45 Unrealized @ Report Date —
— OXFORD IMMUNOTEC GLOBAL PLC 1.8%
Value $3.286M Shares 263,974 Share Price $12.45 Est. Cost/Share $12.45 Unrealized @ Report Date —
— CANCER GENETICS INC 1.6%
Value $2.925M Shares 1,772,741 Share Price $1.65 Est. Cost/Share $1.85 Unrealized @ Report Date —
— MEDICREA INTERNATIONAL 1.5%
Value $2.778M Shares 714,729 Share Price $3.89 Est. Cost/Share $3.60 Unrealized @ Report Date —
— STEADYMED LTD 1.3%
Value $2.344M Shares 721,308 Share Price $3.25 Est. Cost/Share $3.64 Unrealized @ Report Date —
— INVUITY INC 1.0%
Value $1.952M Shares 507,028 Share Price $3.85 Est. Cost/Share $3.85 Unrealized @ Report Date —
— GEMPHIRE THERAPEUTICS INC 0.8%
Value $1.581M Shares 242,812 Share Price $6.51 Est. Cost/Share $6.51 Unrealized @ Report Date —
— SIERRA ONCOLOGY INC 0.6%
Value $1.182M Shares 570,987 Share Price $2.07 Est. Cost/Share $2.07 Unrealized @ Report Date —
— INVITAE CORP 0.6%
Value $1.027M Shares 219,022 Share Price $4.69 Est. Cost/Share $4.69 Unrealized @ Report Date —
— ZOSANO PHARMA CORP 0.5%
Value $1.008M Shares 200,000 Share Price $5.04 Est. Cost/Share $5.04 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 0.4%
Value $666K Shares 129,756 Share Price $5.13 Est. Cost/Share $5.13 Unrealized @ Report Date —
EOLS EVOLUS INC 0.3%
Value $535K Shares 59,229 Share Price $9.03 * Est. Cost/Share $11.44 Unrealized @ Report Date 0.0%
— IMMUNE DESIGN CORP 0.3%
Value $532K Shares 161,226 Share Price $3.30 Est. Cost/Share $3.30 Unrealized @ Report Date —
— SCYNEXIS INC 0.3%
Value $509K Shares 380,083 Share Price $1.34 Est. Cost/Share $1.34 Unrealized @ Report Date —
— EYENOVIA INC 0.2%
Value $365K Shares 39,902 Share Price $9.15 Est. Cost/Share $9.15 Unrealized @ Report Date —
— AQUINOX PHARMACEUTICALS INC 0.2%
Value $287K Shares 20,374 Share Price $14.09 Est. Cost/Share $11.75 Unrealized @ Report Date —